Amendment No.2 to Settlement Agreement and Mutual General ReleaseSettlement Agreement and Mutual General Release • July 15th, 2024 • MediWound Ltd. • Medicinal chemicals & botanical products
This Amendment No.2 to Settlement Agreement and Mutual General Release (this “Second Amendment”) is made effective of July 15, 2024 (the “Effective Date”) by and between Teva Pharmaceutical Industries Ltd. ("Teva"), on the one hand, and MediWound Ltd. ("MediWound"), on the other hand. Teva and MediWound are together referred to as the "Parties" and individually referred to as a “Party”.
